Researchers at Cedars-Sinai Medical Center in Los Angeles are preparing to embark on human trials after promising results in rabbits. Their drug reached brain cells and reduced muscle and movement problems. The Stroke Association said it was the "first significant research" suggesting that the compound could aid stroke patients.